Vasee Moorthy & Gilead Sciences

Vasee Moorthy: Vasee Moorthy, a World Health Organization Science and Strategy senior adviser, stated that the most promising candidate vaccine for the Bundibugyo virus would not be available for at least six to nine months.

Gilead Sciences: Gilead Sciences is a key partner in the urgent high-level coordination meeting convened by United States — Centers for Disease Control and Prevention, potentially involved in assessing medical countermeasures for the Ebola outbreak.

Vasee Moorthy: Vasee Moorthy>>> is a World Health Organization>>> advisor who provided details on the development timeline and status of candidate vaccines for the Bundibugyo species of Ebola.

Gilead Sciences: Gilead Sciences' antiviral drug remdesivir and experimental drug obeldesivir are being prioritized for clinical trials to treat or prevent the Bundibugyo ebolavirus, indicating its significant role in potential therapies.